This provider's $16.7M in total Medicare payments ranks in the 99th percentile of Diagnostic Radiology providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $1.4K | $362.94 | 3.79x | $1.0K | $1.6M | 4.4K | 3.5K |
| 2015 | $1.4K | $345.79 | 4.07x | $1.1K | $1.6M | 4.6K | 3.6K |
| 2016 | $1.4K | $338.56 | 4.02x | $1.0K | $1.8M | 5.1K | 4.1K |
| 2017 | $1.2K | $332.02 | 3.56x | $849.64 | $1.8M | 4.8K | 3.9K |
| 2018 | $980.24 | $340.38 | 2.88x | $639.86 | $1.7M | 4.7K | 4.0K |
| 2019 | $989.28 | $348.97 | 2.83x | $640.31 | $1.4M | 3.3K | 3.0K |
| 2020 | $994.88 | $371.78 | 2.68x | $623.10 | $1.6M | 3.2K | 2.7K |
| 2021 | $1.1K | $452.52 | 2.38x | $625.90 | $1.9M | 3.2K | 2.9K |
| 2022 | $1.1K | $493.67 | 2.32x | $651.71 | $1.6M | 2.7K | 2.4K |
| 2023 | $1.1K | $456.54 | 2.36x | $619.10 | $1.6M | 2.5K | 2.2K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 78815 | Nuclear medicine study with CT imaging skull base to mid-thigh | 7.0K | $9.8M | $1.4K | 2.44x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 6.0K | $1.6M | $270.40 | 2.29x |
| 78816 | Nuclear medicine study with CT imaging whole body | 915 | $1.2M | $1.4K | 2.92x |
| 74177 | CT scan of abdomen and pelvis with contrast | 3.6K | $1.0M | $288.29 | 5.49x |
| 78802 | Nuclear medicine study of radioactive material distribution at tumor locations in whole body, single day imaging | 2.7K | $819.3K | $300.10 | 1.78x |
| 71260 | CT scan chest with contrast | 3.6K | $691.6K | $192.23 | 3.61x |
| 70460 | CT scan head or brain with contrast | 3.3K | $486.0K | $146.97 | 4.38x |
| 74176 | CT scan of abdomen and pelvis | 1.7K | $302.3K | $182.46 | 6.05x |
| 71250 | CT scan chest | 1.8K | $261.5K | $145.04 | 3.99x |
| 70450 | CT scan head or brain | 1.6K | $166.5K | $105.39 | 4.88x |
| 78608 | Nuclear medicine study brain with metabolic evaluation | 50 | $75.0K | $1.5K | 2.03x |
| 74178 | CT scan of abdomen and pelvis before and after contrast | 155 | $51.8K | $334.04 | 4.90x |
| A9588 | Fluciclovine f-18, diagnostic, 1 millicurie | 114 | $41.6K | $365.04 | 1.41x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 78 | $37.1K | $475.70 | 1.30x |
| 78492 | Nuclear medicine study heart muscle at rest and/or stress multiple studies | 23 | $29.4K | $1.3K | 3.92x |
| 71270 | CT scan chest before and after contrast | 92 | $17.2K | $186.41 | 4.59x |
| A9526 | Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries | 23 | $7.2K | $313.60 | 1.28x |
| 76376 | 3D radiographic procedure | 272 | $5.9K | $21.68 | 9.23x |
| 82565 | Blood creatinine level | 755 | $4.1K | $5.45 | 3.98x |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with EKG monitoring, physician supervision, interpretation, and report | 23 | $1.4K | $60.05 | 5.00x |
This provider submits charges 2.85 times higher than what Medicare actually pays.
A markup ratio of 2.85x means for every $100 Medicare pays, this provider initially charges $285. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Diagnostic Radiology providers in NY for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Mark Lodespoto, M.D. | Oceanside, NY | $34.9M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data